Integrated metabolomics-based system for rapid antibiotic susceptibility testing of microbes. Combines identification and susceptibility assessment on a single platform to guide antimicrobial therapy selection.
Manufactured by
Rapid Infection Diagnostics Inc.
Canada
Rapid Infection Diagnostics Inc. (RID) is transforming large, consolidated lab diagnostic solutions by offering a sub-5-hour platform that identifies pathogens and performs antibiotic susceptibility testing (AST). Their metabolomics-based approach accelerates the diagnosis of blood or urine infections and enables clinicians to select the right antibiotic when it matters most.
© 2026 Suplivia · Home · Browse Products